During pregnancy, high blood pressure disorder is the most common medical complication in pregnancy. It is the foremost cause of maternal mortality and perinatal diseases. Vascular endothelial growth factor (VEGF) affects the growth of vascular endothelial cells, existence, and multiplying, which are known to be expressed in the human placenta. This study aimed to identify the expression VEGF in the placenta of hypertension and normotensive women. In this study, a cross-sectional study from november 2019 to February 2020. A total of 100 placentae involved 50 hypertensive cases and 50 normotensive groups were assessed. VEGF-A expression in two placentas groups was evaluated by immunohistochemistry techniques. Strong and moderate VEGF expression was seen in syncytiotrophoblasts, stromal and endothelial cells of hypertensive cases, while not seen in hypertensive cases. There were statistically significant differences in VEGF-A expression between hypertensive cases and normotensive group. In conclusion, VEGF-A expression was significantly increased in each of syncytiotrophoblasts, stroma and endothelial cells in the placenta of hypertensive cases, and it could be used to predict the development of hypertension.
